New York, NY, United States of America

Chuya Lee

This inventor holds 2 USPTO granted patents. Top assignee: Breeden Brothers, LLC. Active years: 2017-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chuya Lee. Retrieved from https://idiyas.com/inventor/chuya-lee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.7

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2017-2018

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Chuya Lee

Introduction

Chuya Lee is a notable inventor based in New York, NY, who has made significant contributions to the field of product design. With a total of two patents to his name, he has demonstrated a commitment to innovation and practicality in his inventions.

Latest Patents

Chuya Lee's latest patents include a pill bottle with a cap and a pill container. These inventions reflect his focus on enhancing user experience and safety in medication management.

Career Highlights

Chuya Lee is currently employed at Breeden Brothers, LLC, where he applies his inventive skills to develop practical solutions. His work at the company showcases his dedication to advancing product design and functionality.

Collaborations

Chuya has collaborated with talented coworkers, including Duncan Edwards and Tony Breeden, to bring innovative ideas to fruition. Their teamwork has contributed to the success of various projects within the company.

Conclusion

Chuya Lee's contributions to innovation through his patents and collaborative efforts highlight his role as a significant figure in the field of product design. His work continues to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…